β¨ Medicines Distribution Consents
15 APRIL NEW ZEALAND GAZETTE 1075
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 7th day of April 1999.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go2750
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Budesonide 1 mg/mL | Spray, nasal suspension | Douglas Pharmaceuticals Limited, Henderson, Auckland | Amcal Budesonide Nasal Spray |
| Pholcodine 0.2% w/v | Linctus | Douglas Pharmaceuticals Limited, Mount Wellington, Auckland | Amcal Cough Suppressant Double Strength |
| Pholcodine 0.1% w/v | Linctus | Douglas Pharmaceuticals Limited, Mount Wellington, Auckland | Amcal Cough Suppressant Regular Strength |
| Choline theophyllinate 1.5% guaiphenesin 0.75% w/v | Syrup | Douglas Pharmaceuticals Limited, Mount Wellington, Auckland | Amcal Expectorant Syrup |
| Paracetamol 24 mg/mL | Suspension, oral | Douglas Pharmaceuticals Limited, Mount Wellington, Auckland | Amcal Paracetamol Pain & Fever Relief |
| Paracetamol 500 mg | Tablet | Douglas Pharmaceuticals Limited, Henderson, Auckland | Amcal Paracetamol Pain Relief |
| Dolomite 400 mg | Tablet, chewable | Viminco A/S., Skaelskor, Denmark | Frutin |
| Paracetamol 2.4% w/v | Suspension, oral | PSM Healthcare Limited, Wiri, Auckland | Pharmacare Paramol Junior Suspension |
| Pholcodine 1 mg/mL | Linctus | PSM Healthcare Limited, Wiri, Auckland | Pholcodine Linctus |
| Pholcodine 2 mg/mL | Linctus | PSM Healthcare Limited, Wiri, Auckland | Pholcodine Strong Linctus |
Dated this 7th day of April 1999.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go2751
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Filgrastim 300 Β΅g/mL | Injection, powder | F Hoffmann-La Roche Limited, Basle, Switzerland; Parkedale Pharmaceuticals Inc., Rochester, Michigan, United States of America; and Amgen Inc., Juncos, Puerto Rico | Neupogen |
| Filgrastim 600 Β΅g/mL | Injection, pre-filled syringe | F Hoffmann-La Roche Limited, Basle, Switzerland; and Parkedale Pharmaceuticals Inc., Rochester, Michigan, United States of America | Neupogen |
Dated this 7th day of April 1999.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go2752
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 45
NZLII —
NZ Gazette 1999, No 45
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of a New Medicine
π₯ Health & Social Welfare7 April 1999
Medicines Act 1981, New Medicine, Provisional Consent, Distribution
- G. R. Boyd, Chief Advisor, Regulation and Safety
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare7 April 1999
Medicines Act 1981, Changed Medicine, Distribution, Filgrastim
- G. R. Boyd, Chief Advisor, Regulation and Safety